- ProQR Therapeutics (NASDAQ:PRQR) priced its previously announced underwritten public offering of 18M ordinary shares at a public offering price of $3.50 per share.
- Total gross proceeds are expected to be $63M.
- Underwriters have a 30-day option to purchase up to 2.7M

